Company intelligence / Profile preview

Soulbrain Holdings

Seongnam, Gyeonggi, South Koreasoulbrainholdings.co.kr ↗

Ownership: Private
Employees: ~1465
Development stage: Other

Overview

Soulbrain Holdings operates globally with a focus on specialty chemicals for semiconductors, displays, batteries, as well as expanding into life sciences through its Bio/Healthcare Institute. Its U.S.-based ARK Diagnostics subsidiary develops commercial immunoassays for TDM, UDT, and veterinary applications with over 50 patents filed or granted[1][2][5].

Therapeutic areas: Other
Modalities: Immunodiagnostics reagentsSpecialty diagnostics reagentsVeterinary diagnostics reagents
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Soulbrain Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soulbrain Holdings.

Explore the full profile